Additionally, compared with those in the control group, the number of NeuN+ cells in the model group was significantly lower, whereas the number of NeuN+ cells in SCLM-pretreated stroke rats was greater than that in saline-treated stroke rats in a dose-dependent manner (Figures 2e,h and Supplementary Figure S1). This evidence concerns the gene RBFOX3 and stroke disorder.